Dr. Regan with Stock News Now

by | Nov 18, 2021 | Investor Information

Home » Investor Information » Dr. Regan with Stock News Now

Dr. Jack Regan discusses scaling MiQLab production and preparing for SNN Network’s Summer Virtual Event, the premier event in MicroCap Finance, with Stock News Now’s CEO Robert Kraft.

Hear the latest on what’s happening with LexaGene as it prepares for its conferences and tradeshow exhibitions.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

There is Even a Black Friday for Buying Capital Equipment

LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.

Red Rover, Red Rover, Send PCR Testing Over

When thinking about how best to isolate a bacterium, scientists were often held to the standards of taking time to grow cultures in laboratories, a process involving days or weeks to simply prepare the sample for testing. In today’s everchanging world, LexaGene’s MiQLab™ now allows for samples to be captured at point-of-care, inserted into a cartridge, mixed with a reagent, and run through a testing system, shortening the time to result to hours instead of days.

Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

More than ever, vet practices are looking for efficient and cost-effective methodologies to take control of these variables and manage costs.

Upcoming Events

Access to Giving

Virtual
July 13, 2021 - July 15, 2021
Access to Giving is a first-of-its-kind virtual investor conference where companies from microcap all the way up to megacap will have the opportunity to present their story and conduct 1x1 meetings with qualified investors, for charity.

Latest Resources


Listen to CEO and Founder, Dr. Jack Regan tell the LexaGene story to prospective investors, October 7, 2021.